Oral versus inhaled antibiotics for non‐cystic fibrosis bronchiectasis
Sign Up to like & getrecommendations! Published in 2017 at "Cochrane Database of Systematic Reviews"
DOI: 10.1002/14651858.cd012579
Abstract: This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To determine the comparative efficacy and safety of oral versus inhaled antibiotics in the treatment of adults and children with noncystic… read more here.
Keywords: oral versus; inhaled antibiotics; fibrosis bronchiectasis; versus inhaled ... See more keywords
Use of inhaled antibiotics among Danish patients with cystic fibrosis
Sign Up to like & getrecommendations! Published in 2022 at "Pediatric Pulmonology"
DOI: 10.1002/ppul.25942
Abstract: Inhaled antibiotics are an important part of cystic fibrosis (CF) airway disease management and should be individualized to fit the microorganism and match patient needs. To investigate the implementation of personalized treatment, this study mapped… read more here.
Keywords: inhaled antibiotics; antibiotics among; use inhaled; among danish ... See more keywords
The Answer for Inhaled Antibiotics in Pneumonia Is Still Blowing in the Wind.
Sign Up to like & getrecommendations! Published in 2017 at "Chest"
DOI: 10.1016/j.chest.2016.11.034
Abstract: Infection remains a daily challenge in the care of critically ill patients. Point prevalence studies suggest that nearly 50% of patients in ICUs globally suffer from acute infection. Pneumonia accounts for more than half of… read more here.
Keywords: inhaled antibiotics; pneumonia still; still blowing; answer inhaled ... See more keywords
Inhaled antibiotics for treatment of adults with non-cystic fibrosis bronchiectasis: A systematic review and meta-analysis.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of internal medicine"
DOI: 10.1016/j.ejim.2021.04.009
Abstract: BACKGROUND Inhaled antibiotics (IA) in non-cystic fibrosis bronchiectasis (NCFB) are recommended by some clinical practice guidelines for prevention or treatment of NCFB exacerbations. METHODS We performed a systematic review and meta-analysis to evaluate the efficacy… read more here.
Keywords: non cystic; treatment; inhaled antibiotics; meta analysis ... See more keywords
The efficacy of inhaled antibiotics in non-cystic fibrosis bronchiectasis
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2018.1500179
Abstract: ABSTRACT Introduction: Non-cystic fibrosis bronchiectasis (NCFB) is considered a chronic heterogenic pulmonary disease, characterized by the permanent and abnormal enlargement and thickening of bronchial walls, impaired mucociliary clearance, and suppuration. Inhaled antibiotics have been used… read more here.
Keywords: non cystic; cystic fibrosis; fibrosis bronchiectasis; inhaled antibiotics ... See more keywords
Assessing effects of inhaled antibiotics in adults with non-cystic fibrosis bronchiectasis––experiences from recent clinical trials
Sign Up to like & getrecommendations! Published in 2018 at "Expert Review of Respiratory Medicine"
DOI: 10.1080/17476348.2018.1503540
Abstract: ABSTRACT Introduction: Non-cystic fibrosis bronchiectasis (NCFB) results from a permanent and progressive destruction of the airways leading to poor lung function. NCFB is characterized by recurrent lung infection, sputum production, and cough, often requiring long-term… read more here.
Keywords: non cystic; cystic fibrosis; inhaled antibiotics; bronchiectasis ... See more keywords
The Rationale and Evidence for Use of Inhaled Antibiotics to Control Pseudomonas aeruginosa Infection in Non-cystic Fibrosis Bronchiectasis
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Aerosol Medicine and Pulmonary Drug Delivery"
DOI: 10.1089/jamp.2017.1415
Abstract: Abstract Non-cystic fibrosis bronchiectasis (NCFBE) is a chronic inflammatory lung disease characterized by irreversible dilation of the bronchi, symptoms of persistent cough and expectoration, and recurrent infective exacerbations. The prevalence of NCFBE is on the… read more here.
Keywords: non cystic; cystic fibrosis; pseudomonas aeruginosa; inhaled antibiotics ... See more keywords
Advances in inhaled antibiotics for management of respiratory tract infections.
Sign Up to like & getrecommendations! Published in 2023 at "Current opinion in pulmonary medicine"
DOI: 10.1097/mcp.0000000000000952
Abstract: PURPOSE OF REVIEW The incidence of bacterial respiratory tract infections is growing. In a context of increasing antibiotic resistance and lack of new classes of antibiotics, inhaled antibiotics emerge as a promising therapeutic strategy. Although… read more here.
Keywords: antibiotics management; tract infections; inhaled antibiotics; respiratory tract ... See more keywords
Didn’t inhale? Time to reconsider aerosolized antibiotics in the treatment of ventilator-associated pneumonia
Sign Up to like & getrecommendations! Published in 2018 at "Critical Care"
DOI: 10.1186/s13054-018-2205-8
Abstract: “The War on Drugs” in the 1970s had an unintended effect on the illegal cannabis industry, increasing domestic production such that cannabis has become among the most profitable cash crops in the United States [1].… read more here.
Keywords: aerosolized antibiotics; inhaled antibiotics; use; associated pneumonia ... See more keywords
Blood mRNA biomarkers distinguish variable systemic and sputum inflammation at treatment initiation of inhaled antibiotics in cystic fibrosis: A prospective non-randomized trial
Sign Up to like & getrecommendations! Published in 2022 at "PLoS ONE"
DOI: 10.1371/journal.pone.0267592
Abstract: Inhaled antibiotics control chronic airway infection and maintain respiratory health in cystic fibrosis (CF). Given variation in patient responses to inhaled antibiotics, the ability to identify distinct responder phenotypes would facilitate the delivery of personalized… read more here.
Keywords: inflammation; panel; inhaled antibiotics; blood ... See more keywords
Cystic Fibrosis: Recent Insights into Inhaled Antibiotic Treatment and Future Perspectives
Sign Up to like & getrecommendations! Published in 2021 at "Antibiotics"
DOI: 10.3390/antibiotics10030338
Abstract: Although new inhaled antibiotics have profoundly improved respiratory diseases in cystic fibrosis (CF) patients, lung infections are still the leading cause of death. Inhaled antibiotics, i.e., colistin, tobramycin, aztreonam lysine and levofloxacin, are used as… read more here.
Keywords: cystic fibrosis; inhaled antibiotics; treatment; inhaled antibiotic ... See more keywords